Published in J Thorac Cardiovasc Surg on November 01, 1995
Per-operative stent placement in the right pulmonary artery; a hybrid technique for the management of pulmonary artery branch stenosis at the time of pulmonary valve replacement in adult Fallot patients. Neth Heart J (2011) 1.05
Pulmonary vein stenosis: initial experience with cutting balloon angioplasty. Heart (2005) 0.95
Total Anomalous Pulmonary Vein Connection: Diagnosis, Management, and Outcome. Curr Treat Options Cardiovasc Med (2004) 0.82
Delivery of stents to target lesions: techniques of intraoperative stent implantation and intraoperative angiograms. Pediatr Cardiol (2005) 0.79
Intraoperative hybrid left pulmonary artery stenting. Ann Pediatr Cardiol (2013) 0.77
Catheterisation laboratory is the place for rehabilitating the pulmonary arteries. Ann Pediatr Cardiol (2008) 0.75
Hybrid intraoperative pulmonary artery stenting in redo congenital cardiac surgeries. Indian Heart J (2013) 0.75
Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG). J Exp Med (1972) 6.13
Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol (1989) 4.69
The dissociation of the attachment and ingestion phases of phagocytosis by macrophages. Exp Cell Res (1967) 4.64
Transcatheter occlusion of the persistently patent ductus arteriosus. Forty-month follow-up and prevalence of residual shunting. Circulation (1991) 3.90
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg (1999) 3.04
Aortic dissection after stent dilatation for coarctation of the aorta: a case report and literature review. Catheter Cardiovasc Interv (2003) 2.82
Preclinical evaluation of a rheolytic catheter for percutaneous coronary artery/saphenous vein graft thrombectomy. J Invasive Cardiol (1999) 2.66
Studies on the immunoglobulins which stimulate the ingestion of glutaraldehyde-treated red cells attached to macrophages. J Immunol (1967) 2.46
Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol (1979) 2.40
Isolated ductus arteriosus aneurysm in the fetus and infant: a multi-institutional experience. J Am Coll Cardiol (2000) 2.36
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol (1998) 2.32
Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol (1997) 2.16
Attachment of modified erythrocytes to phagocytic cells in absence of serum. Proc Soc Exp Biol Med (1967) 2.11
Pulmonary valve replacement late after repair of tetralogy of Fallot. Ann Thorac Surg (1997) 2.08
Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr (1992) 2.03
ABO-incompatible heart transplantation in infants. N Engl J Med (2001) 2.01
Intramyocardial pH during elective arrest of the heart: relative effects of hypothermia versus potassium cardioplegia on anaerobic metabolism. Ann Thorac Surg (1980) 2.01
Stenting of the right ventricular outflow tract in the symptomatic infant with tetralogy of Fallot. Heart (2008) 1.99
Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation (1978) 1.97
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med (2000) 1.97
Selective phagocytic paralysis induced by immobilized immune complexes. J Exp Med (1975) 1.96
Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol (1998) 1.92
Combined antegrade and retrograde dilation: a new endoscopic technique in the management of complex esophageal obstruction. Gastrointest Endosc (2001) 1.91
Scimitar syndrome: twenty years' experience and results of repair. J Thorac Cardiovasc Surg (1996) 1.90
Phagocytosis: the engulfment stage. Semin Hematol (1968) 1.89
Macrophage spreading in vitro. I. Inducers of spreading. Exp Cell Res (1973) 1.88
Insulin resistance in pulmonary arterial hypertension. Eur Respir J (2008) 1.80
Cell shape changes induced by cationic anesthetics. J Exp Med (1976) 1.78
The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era. J Thorac Cardiovasc Surg (1997) 1.78
Dilated cardiomyopathy with neutropenia, short stature, and abnormal carnitine metabolism. J Pediatr (1988) 1.76
Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg (2001) 1.76
Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest (2000) 1.74
Evolving strategies and improving outcomes of the modified norwood procedure: a 10-year single-institution experience. Ann Thorac Surg (2001) 1.67
Iliofemoral arterial complications of balloon angioplasty for systemic obstructions in infants and children. Circulation (1990) 1.65
Chloride channel inhibition blocks the protection of ischemic preconditioning and hypo-osmotic stress in rabbit ventricular myocardium. Circ Res (1999) 1.65
Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nat Med (1999) 1.64
Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol (1997) 1.64
Micro magnetic resonance angiography of the finger in systemic sclerosis. Rheumatology (Oxford) (2008) 1.58
Repair of coarctation of the aorta in children: postoperative morphology. Radiology (1991) 1.58
Short-term effect of monocuspid valves on pulmonary insufficiency and clinical outcome after surgical repair of tetralogy of Fallot. J Thorac Cardiovasc Surg (1996) 1.57
Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol (1988) 1.57
Morphologic and hemodynamic consequences after percutaneous balloon valvotomy for neonatal pulmonary stenosis: medium-term follow-up. J Am Coll Cardiol (1996) 1.57
Scimitar syndrome in infancy. J Am Coll Cardiol (1993) 1.52
Endovascular stents in the pulmonary circulation. Clinical impact on management and medium-term follow-up. Circulation (1995) 1.52
Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol (1981) 1.51
Effect of antiserum on the attachment of modified erythrocytes to normal or to trypsinized macrophages. Proc Soc Exp Biol Med (1968) 1.50
Transcatheter perforation of the right ventricular outflow tract as initial therapy for pulmonary valve atresia and intact ventricular septum in the newborn. Cathet Cardiovasc Diagn (1997) 1.49
Pre-closure of femoral venous access sites used for large-sized sheath insertion with the Perclose device in adults undergoing cardiac intervention. Heart (2006) 1.49
Subaortic stenosis in the spectrum of atrioventricular septal defects. Solutions may be complex and palliative. J Thorac Cardiovasc Surg (1995) 1.49
Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc Natl Acad Sci U S A (2001) 1.48
Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization. Am J Physiol Lung Cell Mol Physiol (2009) 1.47
Vaccinating badgers (Meles meles) against Mycobacterium bovis: the ecological considerations. Vet J (2003) 1.47
Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest (1986) 1.47
Use of the local anesthetic lidocaine for cell harvesting and subcultivation. In Vitro (1976) 1.47
Hemodynamic unloading leads to regression of pulmonary vascular disease in rats. J Thorac Cardiovasc Surg (2001) 1.46
Growth and development of the pulmonary vascular bed in patients with tetralogy of Fallot with or without pulmonary atresia. Circulation (1981) 1.46
Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect Immun (1999) 1.43
Uptake of aldehyde-treated erythrocytes by L2 cells: inhibition by anti-red cell antibody or by coating the erythrocytes with purified proteins. Exp Cell Res (1969) 1.42
The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr (1981) 1.42
Regional ventricular wall motion abnormalities in tricuspid atresia after the Fontan procedure. J Am Coll Cardiol (1993) 1.42
Stenting of coronary artery stenosis in Kawasaki disease. Catheter Cardiovasc Interv (1999) 1.41
Complete atrioventricular septal defects: results of repair, risk factors, and freedom from reoperation. Circulation (1997) 1.40
Subaortic stenosis, the univentricular heart, and banding of the pulmonary artery: an analysis of the courses of 43 patients with univentricular heart palliated by pulmonary artery banding. Circulation (1986) 1.40
Right-to-left shunt following repair of partial anomalous pulmonary venous connection: a novel use of the Rashkind double-umbrella occlusion device. Cathet Cardiovasc Diagn (1994) 1.39
Catheter occlusion of the persistently patent ductus arteriosus. Am J Cardiol (1988) 1.38
Validation of Doppler-derived pulmonary arterial pressure in patients with ductus arteriosus under different hemodynamic states. Circulation (1987) 1.36
Ventilatory predictors of pulmonary hypoplasia in congenital diaphragmatic hernia, confirmed by morphologic assessment. J Pediatr (1987) 1.35
Endovascular stents in the management of coarctation of the aorta in the adolescent and adult: one year follow up. Heart (2001) 1.35
Reliable microsatellite genotyping of the Eurasian badger (Meles meles) using faecal DNA. Mol Ecol (2003) 1.34
Two-dimensional echocardiographic and color flow Doppler evaluation of ductal occlusion with the Rashkind prosthesis. Circulation (1989) 1.34
Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation (1984) 1.34
Abnormal distribution of pulmonary blood flow after the Glenn shunt or Fontan procedure: risk of development of arteriovenous fistulae. Circulation (1985) 1.34
Intravascular stent prosthesis for right ventricular outflow obstruction. J Am Coll Cardiol (1992) 1.33
Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device. Circulation (1993) 1.33
Extracardiac conduit versus lateral tunnel cavopulmonary connections at a single institution: impact on outcomes. J Thorac Cardiovasc Surg (2001) 1.31
Dissociation of force from myofibrillar MgATPase and stiffness at short sarcomere lengths in rat and toad skeletal muscle. J Physiol (1989) 1.30
The 67-kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase. J Clin Invest (1993) 1.29
Phagocytosis of modified erythrocytes by macrophages and L2 cells. Exp Cell Res (1969) 1.29
Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J Clin Invest (1991) 1.28
Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly. J Virol (1997) 1.27
Temperature dependence of the inhibitory effects of orthovanadate on shortening velocity in fast skeletal muscle. Biophys J (1994) 1.27
Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr (1991) 1.26
A mechanistic approach to blood flow occlusion. Int J Sports Med (2009) 1.26
Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J (1988) 1.25
A case of spontaneous resolution of idiopathic pulmonary hypertension. Br Heart J (1981) 1.24
Impact of dynamic 3D transoesophageal echocardiography in the assessment of atrial septal defects and occlusion by the double-umbrella device (CardioSEAL) Cardiol Young (1998) 1.22
Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev Biol (1991) 1.21
Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr (2001) 1.20
Influence of load and stretch shortening cycle on the kinematics, kinetics and muscle activation that occurs during explosive upper-body movements. Eur J Appl Physiol Occup Physiol (1997) 1.20
Potential safety issues with blood flow restriction training. Scand J Med Sci Sports (2011) 1.20
Phagocytosis of erythrocytes by Acanthamoeba sp. Exp Cell Res (1971) 1.20
Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity. Am J Physiol (1991) 1.19
Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res (1994) 1.19
Incidence and predictors of ARDS after cardiac surgery. Chest (2001) 1.19